- Home
- Depression
Depression
Is this the end of one-size-fits-all treatments for depression?
For World Mental Health Day, learn how Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
Quiz: How much do you know about insomnia?
Plenty of things can come between you and a good night’s sleep: stress, anxiety and pain, to name a few. In honor of Better Sleep Month, take this quiz to test your insomnia IQ—and get expert-approved tips on how to up the number of Zzzs you get every night.
How a support group went virtual to help kids cope with COVID-19 anxiety
As the pandemic spread, many young people experienced anger, stress—even depression. But a Save the Children initiative supported by Johnson & Johnson is teaching them how to manage their difficult emotions.
How Johnson & Johnson is supporting the next great leaders in mental health
Meet four students dedicated to removing the stigma of mental illness and increasing access to crucial treatments around the world—with the help of the Global Mental Health Scholarship Fund.
This researcher made good on his high school promise to improve how we treat depression
As a teenager, Wayne Drevets, M.D., had friends who struggled with depression—and who ultimately inspired him to focus his career on helping people with the debilitating disorder.
Battling the baby blues: Meet 3 researchers whose innovative work is all about boosting the mental health of moms
A staggering 1 in 7 women suffer from perinatal mood disorders, which can begin as early as pregnancy. We take a look at how these scientists are working to find ways to help halt depression in moms at the most critical juncture: before it starts.
3 innovative ways one company is helping rethink how we treat mental healthcare
From scientists in research labs to CEOs at companies across the country, here’s how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.
Johnson & Johnson’s new Chief Financial Officer answers 7 popular investor questions
Joe Wolk, who has enjoyed a 20-year tenure at Johnson & Johnson, shares his vision for the company’s fiscal future.
4 things we now know about treatment-resistant depression
Imagine being depressed and trying medication after medication—only to find none work. That’s the plight of people with treatment-resistant depression. We look at this little-understood condition, and how researchers are working to crack its code.
How Johnson & Johnson is doing its part to tackle the worldwide mental health epidemic
With company leaders at the World Economic Forum in Davos this week, Johnson & Johnson’s Chief Scientific Officer weighs in on the next great global healthcare challenge—and how we can all come together to help address it.